Search Results

[Anti-PCSK9 in coronary artery disease: genetic progress, therapeutic approaches].

• Authors : Abifadel M; Ghaleb Y; Elbitar S

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Coronary Artery Disease/Coronary Artery Disease/Coronary Artery Disease/*therapy ; Proprotein Convertases/Proprotein Convertases/Proprotein Convertases/*immunology

• Source: La Revue du praticien [Rev Prat] 2015 Mar; Vol. 65 (3), pp. 326-7.Publisher: J.-B. Baillière Country of Publication: France NLM ID: 0404334 Publication Model: Print Cited Medium: Print ISSN: 0035-2640 (Print)

Record details

[PCSK9 inhibitors: new treatment to lower cholesterol].

• Authors : Gencer B; Rodondi N; Mach F

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cholesterol, LDL/Cholesterol, LDL/Cholesterol, LDL/*drug effects

• Source: Revue medicale suisse [Rev Med Suisse] 2016 Mar 02; Vol. 12 (508), pp. 440-2, 444.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

[PCSK9 inhibitors: emerging treatment to lower cholesterol?].

• Authors : Gencer B; Rodondi N; Mach F

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Hyperlipoproteinemia Type II/Hyperlipoproteinemia Type II/Hyperlipoproteinemia Type II/*drug therapy ; Proprotein Convertases/Proprotein Convertases/Proprotein Convertases/*antagonists & inhibitors

• Source: Revue medicale suisse [Rev Med Suisse] 2014 Mar 05; Vol. 10 (420), pp. 539-42, 544.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

[Lipoprotein (a) :NSFA consensus].

• Authors : Durlach V; Université de Champagne-Ardenne, UMR CNRS 7369 MEDyC, pôle thoracique et cardiovasculaire de Reims, CHU de Reims, Reims, France.; Anglés-Cano E

Subjects: Lipoprotein(a)*/Lipoprotein(a)*/Lipoprotein(a)*/chemistry ; Lipoprotein(a)*/Lipoprotein(a)*/Lipoprotein(a)*/genetics ; Proprotein Convertase 9*

• Source: La Revue du praticien [Rev Prat] 2022 Feb; Vol. 72 (2), pp. 123-129.Publisher: J.-B. Baillière Country of Publication: France NLM ID: 0404334 Publication Model: Print Cited Medium: Internet ISSN: 2101-017X

Record details

O26 Les statines et l’absence de PCSK9 activent l’excrétion transintestinale de cholestérol.

• Authors : Le May, C.; Berger, J.-M.; Pillot, B.

Subjects: STATINS (Cardiovascular agents); ENZYME activation; BLOOD lipoproteins

• Source: Diabetes & Metabolism; Mar2013 Supplement 1, Vol. 39, pA6-A7, 0p

Record details

[Current update on PCKS9 inhibitors].

• Authors : Gencer B; Service de cardiologie, HUG, 1211 Genève 14.; Nanchen D

Subjects: Anticholesteremic Agents* ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Hypercholesterolemia*/Hypercholesterolemia*/Hypercholesterolemia*/drug therapy

• Source: Revue medicale suisse [Rev Med Suisse] 2018 Feb 28; Vol. 14 (596), pp. 482-486.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

Des rhumes à la Covid-19 : conséquences neurologiques potentielles d'une infection par les coronavirus.

• Authors : Talbot, Pierre J.; Desforges, Marc

Subjects: CORONAVIRUSES; PERIPHERAL nervous system; CENTRAL nervous system

• Source: Virologie; Jul/Aug2022, Vol. 26 Issue 4, p283-302, 20p

Record details

Les guêpes parasites ont domestiqué des virus à plusieurs reprises au cours de leur évolution.

• Authors : Pichon, Apolline; Bézier, Annie; Barbe, Valérie

• Source: Médecine Sciences; 2016, Vol. 32 Issue 8/9, p699-703, 5p

Record details

Coronavirus respiratoires humains neurotropes.

• Authors : Talbot, Pierre J.; Desforges, Marc; Dube, Mathieu

• Source: Médecine Sciences; 2016, Vol. 32 Issue 8/9, p696-699, 4p

Record details

[PERSONALIZED APPROACH TO LIPID-LOWERING THERAPY].

• Authors : Scheen AJ; Descamps OS

Subjects: Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use ; Precision Medicine/Precision Medicine/Precision Medicine/*methods; Dyslipidemias/Dyslipidemias/Dyslipidemias/drug therapy

• Source: Revue medicale de Liege [Rev Med Liege] 2015 May-Jun; Vol. 70 (5-6), pp. 292-8.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details